Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 7, 2011, Pages 752-759

  Galeano, Mariarosaria ^a   Polito, Francesca ^a   Bitto, Alessandra ^a   Irrera, Natasha ^a   Campo, Giuseppe M ^a   Avenoso, Angela ^a   Calò, Margherita ^b   Cascio, Patrizia Lo ^b   Minutoli, Letteria ^a   Barone, Mauro ^c   Squadrito, Francesco ^a   Altavilla, Domenica ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c and Sophia University Institute   (Italy)

Author keywords

Cyclins; Diabetic mice; Hyaluronic acid; Transglutaminase II

Indexed keywords

CYCLIN B1; HYALURONIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC DISORDER; HISTOLOGY; INCISION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; WOUND HEALING;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; WOUND HEALING;

ANIMALIA; MUS;

EID: 79955609633     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.012     Document Type: Article

References (45)

1. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005, 366:1736-1743.
2. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
3. Reiber G.E., Raugi G.J. Preventing foot ulcers and amputations in diabetes. Lancet 2005, 366:1676-1677.
4. Weigel P.H., Frost S.J., LeBoeuf R.D., McGary C.T. The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. Ciba Found. Symp. 1989, 143:248-261.
5. Kobayashi Y., Okamoto A., Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology 1994, 31:235-244.
6. Iocono J.A., Krummel T.M., Keefer K.A., Allison G.M., Paul H. Repeated additions of hyaluronan alters granulation tissue deposition in sponge implants in mice. Wound Repair Regen. 1998, 6:442-448.
7. Kielty C.M., Whittaker S.P., Grant M.E., Shuttleworth C.A. Type IV collagen microfibrils: evidence for a structural association with hyaluronan. J. Cell Biol. 1992, 118:979-990.
8. Rooney P., Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation 1993, 54:1-9.
9. West D.C., Shaw D.M., Lorenz P., Adzick N.S., Longaker M.T. Fibrotic healing of adult and late gestation fetal wounds correlates with increased hyaluronidase activity and removal of hyaluronan. Int. J. Biochem. Cell Biol. 1997, 29:201-210.
10. Huang-Lee L.L., Nimni M.E. Fibroblast contraction of collagen matrices with and without covalently bound hyaluronan. J. Biomater. Sci. Polym. Ed. 1993, 5:99-109.
11. Heldin P., Laurent T.C., Heldin C.H. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem. J. 1989, 258:919-922.
12. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1991, 228:1324-1326.
13. Lepperdinger G., Mullegger J., Kreil G. Hyal2-less active, but more versatile?. Matrix Biol. 2001, 20:509-514.
14. Formby B., Stern R. Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochem. Biophys. Res. Commun. 2003, 305:203-208.
15. Coleman D.L. Diabetes-obesity syndromes in mice. Diabetes 1982, 31:1-6.
16. MacLachlan T.K., Sang N., Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 1995, 5:127-156.
17. Bohlen H.G., Niggl B.A. Adult microvascular disturbances as a result of juvenile-onset diabetes in db/db mice. Blood Vessels 1979, 16:269-276.
18. Goodson W.H., Hunt T.K. Studies of wound healing in experimental diabetes. J. Surg. Res. 1977, 22:221-227.
19. Yevdokimova N.Y., Podpryatov S.E. Hyaluronic acid production and CD44 expression in cultured dermal fibroblasts of patients with non-insulin-dependent diabetes mellitus with and without chronic ulcers on the lower extremity. Wound Repair Regen. 2005, 13:181-188.
20. Altavilla D., Saitta A., Cucinotta D., Galeano M., Deodato B., Colonna M., Torre V., Russo G., Sardella A., Urna G., Campo G.M., Cavallari V., Squadrito G., Squadrito F. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001, 50:667-674.
21. Bitto A., Minutoli L., Altavilla D., Polito F., Fiumara T., Marini H., Galeano M., Calò M., Lo Cascio P., Bonaiuto M., Migliorato A., Caputi A.P., Squadrito F. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. Pharmacol. Res. 2008, 57:159-169.
22. Bitto A., Minutoli L., Galeano M.R., Altavilla D., Polito F., Fiumara T., Calò M., Lo Cascio P., Zentilin L., Giacca M., Squadrito F. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin. Sci. (Lond) 2008, 114:707-718.
23. Galeano M., Altavilla D., Cucinotta D., Russo G.T., Calò M., Bitto A., Marini H., Marini R., Adamo E.B., Seminara P., Minutoli L., Torre V., Squadrito F. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004, 53:2509-2517.
24. Galeano M., Bitto A., Altavilla D., Minutoli L., Polito F., Calò M., Lo Cascio P., Stagno d'Alcontres F., Squadrito F. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008, 16:208-217.
25. Dechert T.A., Ducale A.E., Ward S.I., Yager D.R. Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen. 2006, 14:252-258.
26. Reed R.K., Lilja K., Laurent T.C. Hyaluronan in the rat with special reference to the skin. Acta Physiol. Scand. 1988, 134:405-411.
27. Fraser J.R., Kimpton W.G., Pierscionek B.K., Cahill R.N.P. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Arthritis Rheum. 1993, 22:9-17.
28. Laurent U.B., Laurent T.C., Hellsing L.K., Persson L., Hartman M., Lilja K. Hyaluronan in human cerebrospinal fluid. Acta Neurol. Scand. 1996, 94:194-206.
29. Prehm P. Hyaluronate is synthesized in plasma membranes. Biochem. J. 1984, 220:579-600.
30. Stair S., Csoka T.B., Stern R. Hyaluronidase expression in human skin fibroblasts. Biochem. Biophys. Res. Commun. 1999, 266:268-273.
31. Bertolami C.N., Berg S., Messadi D.V. Binding and internalisation of hyaluronate by human cutaneous fibroblasts. Matrix 1992, 12:11-21.
32. Price R.D., Myers S., Leigh I.M., Price R.D. The role of hyaluronic acid in wound healing. Am. J. Clin. Dermatol. 2005, 6:393-402.
33. Price R.D., Berry M.G., Navsaria H.A. Hyaluronic acid: the scientific and clinical evidence. J. Plast. Reconstr. Aesthet. Surg. 2007, 60:1110-1119.
34. Chen W.Y., Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep. Reg. 1999, 7:79-89.
35. Stern R., Maibach H.I. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin. Dermatol. 2008, 26:106-122.
36. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006, 85:699-715.
37. Cechowska-Pasko M., Palja J., Bankowski E. Decrease in the glycosaminoglycan content in the skin of diabetic rats. The role of IGF-I, IGF-binding proteins and proteolytic activity. Mol. Cell. Biochem. 1996, 154:1-8.
38. Cechowska-Pasko M., Palja J., Bankowski E. Alterations in glycosaminoglycans in wounded skin of diabetic rats. A possible role of IGF-I, IGF-binding proteins and proteolytic activity. Acta Biochim. Pol. 1996, 43:557-566.
39. Grande J.P. Role of transforming growth factor-beta in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 1997, 214:27-40.
40. Klass B.R., Grobbelaar A.O., Rolfe K.J. Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad. Med. J. 2009, 85:9-14.
41. Adams D.H., Strudwick X.L., Kopecki Z., Hooper-Jones J.A., Matthaei K.I., Campbell H.D., Powell B.C., Cowin A.J. Gender specific effects on the actin remodelling protein flightless I and TGF-beta1 contribute to impaired wound healing in aged skin. Int. J. Biochem. Cell Biol. 2008, 40:1555-1569.
42. Greco R.M., Iocono J.A., Ehrlich H.P. Hyaluronic acid stimulates human fibroblast proliferation within a collagen matrix. J. Cell. Physiol. 1998, 177:465-473.
43. Gao F., Yang C.X., Mo W., Liu Y.W., He Y.Q. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin. Invest. Med. 2008, 31:E106-E116.
44. Altavilla D., Squadrito F., Polito F., Irrera N., Calò M., Lo Cascio P., Galeano M., La Cava L., Minutoli L., Marini H., Bitto A. Activation of adenosine A2(A) receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice. Surgery 2011, 149:253-261.
45. Campo G.M., Avenoso A., Micali A., Nastasi G., Squadrito F., Altavilla D., Bitto A., Polito F., Rinaldi M.G., Calatroni A., D'Ascola A., Campo S. High molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice. Biochim. Biophys. Acta 2010, 1802:1118-1130.